Impact News +++ Bit Digital details January Ethereum holdings and staking metrics (Proactive Investors) +++ BIT DIGITAL Aktie +4,42%

BOSTON SCIENTIFIC Aktie

>Aktienkurs

63.8 EUR -3.3% (Tradegate)

Ask: 64.6 EUR / 470 Stück

Bid: 64.4 EUR / 470 Stück

Tagesumsatz: 4539 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

Aktie über LYNX handeln

Intraday

1 Jahr

>Performance

1 Woche: -18,8%

1 Monat: -23,9%

3 Monate: -24,9%

6 Monate: -27,3%

1 Jahr: -37,5%

laufendes Jahr: -21,6%

>BOSTON SCIENTIFIC Aktie

Name:

BOSTON SCIENTIFIC DL-,01

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US1011371077 / 884113

Symbol/ Ticker:

BSX (Frankfurt) / BSX (NYSE)

Kürzel:

FRA:BSX, ETR:BSX, BSX:GR, NYSE:BSX

Index:

S&P500

Webseite:

http://www.bostonscientif..

Profil:

Boston Scientific Corporation, a leading global me..
>Volltext..

Marktkapitalisierung:

97457.09 Mio. EUR

Unternehmenswert:

97457.09 Mio. EUR

Umsatz:

16991.69 Mio. EUR

EBITDA:

Nettogewinn:

2449.51 Mio. EUR

Gewinn je Aktie:

1.66 EUR

Schulden:

Liquide Mittel:

Operativer Cashflow:

Bargeldquote:

Umsatzwachstum:

5.66%

Gewinnwachstum:

37.66%

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

1 Insider verkaufte innerhalb der letzten 30 Tage Aktien im Wert von 15.043.394 USD.

Suchwörter:

BOSTON SCIENTIFIC

Letzte Datenerhebung:

07.02.26

>Kennzahlen

Aktien/ Unternehmen:

Aktien: 1483.02 Mio. St.

Frei handelbar: 99.62%

Leerverk. Aktien: 1.58%

Rückkaufquote: -

Mitarbeiter: -

Umsatz/Mitarb.: -

Analysten:

Analystenrating: Strong buy

Kursziel: 35.54%

Bewertung:

KGV: 39.97

KGV lG: 22.43

KUV: 5.62

KBV: -

PEG-Ratio: 0.7

EV/EBITDA: -

Rentabilität:

Bruttomarge: 70.32%

Gewinnmarge: 14.42%

Operative Marge: 19.43%

Managementeffizenz:

Gesamtkaprendite: -

Eigenkaprendite: -

>Anleihen

>Peer Group

Gesundheit

>Chart & Kurs - NYSE

>Alle News

06.02.26 - 21:24	Boston Scientific′s Worst Day in 25 Years Surprised Analysts (Bloomberg)
	Few analysts foresaw the disappointing results and profit forecast that sent Boston Scientific Corp.'s shares plummeting nearly 20% this week. Even fewer have given up on their bullish calls since....

06.02.26 - 14:18

The TAVR Pioneer Bets Everything on One Market as Its Competitor Spreads Risk (24/7 Wall St.)

Edwards Lifesciences (NYSE: EW) and Boston Scientific (NYSE: BSX) both reported strong quarters, but the results reveal fundamentally different strategies in the heart device market. Edwards doubled down on transcatheter valve replacement with $1.15 billion in TAVR sales, up 12.4%, while Boston Scientific exited TAVR entirely and leaned into its diversified cardiovascular platform. One Specialist, ... The TAVR Pioneer Bets Everything on One Market as Its Competitor Spreads Risk The post The TAVR Pioneer Bets Everything on One Market as Its Competitor Spreads Risk appeared first on 24/7 Wall St.....

05.02.26 - 17:57	Boston Scientific Analyst Slashes Price Target On Disappointing 2026 Outlook (Benzinga)
	Boston Scientific beats Q4 estimates but gives disappointing 2026 guidance, with slowing organic growth and lowered price target. Latest Ratings for BSX DateFirmActionFromTo Feb 2022Morgan StanleyMaintainsOverweight Feb 2022Raymond JamesMaintainsStrong Buy Feb 2022SVB LeerinkMaintainsMarket Perform View More Analyst Ratings for BSX View the Latest Analyst Ratings Importance Rank: 1 read more...

05.02.26 - 14:33	Boston Scientific Analysts Cut Their Forecasts Following Q4 Results (Benzinga)
	Latest Ratings for BSX DateFirmActionFromTo Feb 2022Morgan StanleyMaintainsOverweight Feb 2022Raymond JamesMaintainsStrong Buy Feb 2022SVB LeerinkMaintainsMarket Perform View More Analyst Ratings for BSX View the Latest Analyst Ratings Importance Rank: 1 read more...

04.02.26 - 23:48	Stock Market Today, Feb. 4: Boston Scientific Plunges After Cautious 2026 Guidance Disappoints Investors (Fool)
	Today, Feb. 4, 2026, investors are weighing Boston Scientific's guidance against new deals and its long-term margin path....

04.02.26 - 21:33	Boston Scientific outlines 10% to 11% organic growth target for 2026 amid continued strength in EP and WATCHMAN (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

04.02.26 - 19:24	Why Boston Scientific Stock Plummeted Today (Fool)
	I'll be keeping a close eye on Boston Scientific stock following the market's peculiar reaction to its solid earnings report....

04.02.26 - 19:24	Boston Scientific (BSX) Earnings Transcript (Fool)
	Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...

04.02.26 - 16:45	Boston Scientific (BSX) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
	While the top- and bottom-line numbers for Boston Scientific (BSX) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values....

04.02.26 - 15:31	Trotz Gewinnplus: Aktie von Boston Scientific fällt vorbörslich deutlich (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

04.02.26 - 15:24	Boston Scientific Profit, Sales Rise but Issues Soft Guidance (WSJ EN)
	Sales rose 16%, but the medical-device maker issued a soft forecast for the year, sending shares down premarket....

04.02.26 - 15:15	Boston Scientific (BSX) Beats Q4 Earnings and Revenue Estimates (Zacks)
	Boston Scientific (BSX) delivered earnings and revenue surprises of +2.96% and +0.39%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?...

04.02.26 - 14:24	Boston Scientific shares slide on cautious 2026 revenue forecast (Reuters EN)
	Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...

04.02.26 - 14:18	ROUNDUP: Boston Scientific Guides Q1, FY26 In Line With Estimates (AFX)
	WASHINGTON (dpa-AFX) - While reporting financial results for the fourth quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) initiated its adjusted earnings and sales growth......

04.02.26 - 13:57	Boston Scientific slips despite Q4 beat as outlook trails consensus (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

04.02.26 - 13:01	Boston Scientific Corp Profit Climbs In Q4 (AFX)
	WASHINGTON (dpa-AFX) - Boston Scientific Corp (BSX) revealed earnings for its fourth quarter that Increases, from last yearThe company's earnings came in at $672 million, or $0.45 per share. This ......

04.02.26 - 12:48	Earnings Snapshot: Boston Scientific guides FY2026 net sales growth of ~10.5–11.5%, adjusted EPS of $3.43–$3.49 (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

04.02.26 - 12:36	Boston Scientific Non-GAAP EPS of $0.80 beats by $0.02, revenue of $5.29B beats by $10M (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

04.02.26 - 12:33	Boston Scientific announces results for fourth quarter and full year 2025 (PR Newswire)
	MARLBOROUGH, Mass., Feb. 4, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $5.286 billion during the fourth quarter of 2025, growing 15.9 percent on a reported basis, 14.3 percent on an operational1 basis and 12.7 percent on an organic2 basis, all......

04.02.26 - 08:39	Boston Scientific Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street′s Most Accurate Analysts (Benzinga)
	Latest Ratings for BSX DateFirmActionFromTo Feb 2022Morgan StanleyMaintainsOverweight Feb 2022Raymond JamesMaintainsStrong Buy Feb 2022SVB LeerinkMaintainsMarket Perform View More Analyst Ratings for BSX View the Latest Analyst Ratings Importance Rank: 1 read more...

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Eine gesunde Meinung wird immer für eine literarische Meinung gehalten. - Jean Cocteau

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram